$RZLT
Rezolute, Inc. Stock $rzlt

$rzlt Overview Financials Valuation SEC Filings Company Website

2017 Q3 Form 10-K Financial Statement

#000114420417049237 Filed on September 22, 2017

Income Statement

Concept	2017 Q3	2017	2016 Q2
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.350M	$7.900M	$1.170M
YoY Change	85.04%	50.76%	-33.52%
% of Gross Profit
Research & Development	$4.311M	$12.09M	$2.650M
YoY Change	73.4%	28.01%	107.03%
% of Gross Profit
Depreciation & Amortization	$266.6K	$1.107M	$260.0K
YoY Change	-0.65%	48.78%	420.0%
% of Gross Profit
Operating Expenses	$6.717M	$20.32M	$3.870M
YoY Change	170.21%	35.94%	25.24%
Operating Profit	-$6.717M	-$20.32M
YoY Change		35.94%
Interest Expense	$0.00	$1.595K	$0.00
YoY Change	-100.0%	-68.35%	-100.0%
% of Operating Profit
Other Income/Expense, Net	$32.52K	$46.92K
YoY Change		197.92%
Pretax Income	-$6.680M	-$20.28M	-$3.870M
YoY Change	74.87%	35.74%	27.3%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$6.685M	-$20.28M	-$3.870M
YoY Change	74.99%	35.76%	27.3%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$6.302M	-$24.43M	-$7.442M
COMMON SHARES
Basic Shares Outstanding	53.73M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2017 Q3	2017	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.020M	$4.490M	$4.060M
YoY Change	19.29%	10.59%	-23.11%
Cash & Equivalents	$4.020M	$4.490M	$4.060M
Short-Term Investments
Other Short-Term Assets	$350.0K	$440.0K	$430.1K
YoY Change	-2.78%	2.33%	34.28%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$4.360M	$4.930M	$4.492M
YoY Change	16.89%	9.8%	-26.56%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.060M	$5.330M	$5.985M
YoY Change	-14.24%	-10.87%	32.26%
Goodwill
YoY Change
Intangibles			$51.61K
YoY Change
Long-Term Investments
YoY Change
Other Assets	$320.0K	$330.0K	$0.00
YoY Change	-15.79%	-13.16%	-100.0%
Total Long-Term Assets	$5.440M	$5.700M	$6.411M
YoY Change	-14.06%	-11.08%	24.57%
TOTAL ASSETS
Total Short-Term Assets	$4.360M	$4.930M	$4.492M
Total Long-Term Assets	$5.440M	$5.700M	$6.411M
Total Assets	$9.800M	$10.63M	$10.90M
YoY Change	-2.58%	-2.48%	-3.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.570M	$1.650M	$1.500M
YoY Change	21.71%	10.0%	6.38%
Accrued Expenses	$0.00	$0.00	$20.00K
YoY Change	-100.0%	-100.0%	100.0%
Deferred Revenue
YoY Change
Short-Term Debt	$10.00K	$10.00K	$60.00K
YoY Change	-83.33%	-83.33%	0.0%
Long-Term Debt Due		$0.00	$20.00K
YoY Change		-100.0%	-77.78%
Total Short-Term Liabilities	$1.690M	$1.770M	$1.731M
YoY Change	13.42%	2.31%	1.2%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$300.0K	$330.0K	$400.0K
YoY Change	-18.92%	-17.5%	-16.66%
Total Long-Term Liabilities	$300.0K	$330.0K	$400.0K
YoY Change	-18.92%	-17.5%	-20.57%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.690M	$1.770M	$1.731M
Total Long-Term Liabilities	$300.0K	$330.0K	$400.0K
Total Liabilities	$1.990M	$2.100M	$2.131M
YoY Change	7.57%	-1.41%	-3.57%
SHAREHOLDERS EQUITY
Retained Earnings			-$44.04M
YoY Change			51.31%
Common Stock			$35.11K
YoY Change			44.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$7.806M	$8.530M	$8.773M
YoY Change
Total Liabilities & Shareholders Equity	$9.800M	$10.63M	$10.90M
YoY Change	-2.58%	-2.48%	-3.19%

Cashflow Statement

Concept	2017 Q3	2017	2016 Q2
OPERATING ACTIVITIES
Net Income	-$6.685M	-$20.28M	-$3.870M
YoY Change	74.99%	35.76%	27.3%
Depreciation, Depletion And Amortization	$266.6K	$1.107M	$260.0K
YoY Change	-0.65%	48.78%	420.0%
Cash From Operating Activities	-$4.905M	-$13.31M	-$3.150M
YoY Change	65.25%	26.9%	60.71%
INVESTING ACTIVITIES
Capital Expenditures	-$10.00K	-$410.0K	-$320.0K
YoY Change	-92.31%	-80.38%	-85.65%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$210.0K	$0.00
YoY Change	-100.0%	-67.19%
Cash From Investing Activities	-$5.816K	-$195.4K	-$310.0K
YoY Change	-90.47%	-86.53%	-86.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$4.440M	$13.93M	5.790M
YoY Change	90.31%	29.84%	363.2%
NET CHANGE
Cash From Operating Activities	-$4.905M	-$13.31M	-3.150M
Cash From Investing Activities	-$5.816K	-$195.4K	-310.0K
Cash From Financing Activities	$4.440M	$13.93M	5.790M
Net Change In Cash	-$470.8K	$424.5K	2.330M
YoY Change	-32.38%	-135.08%	-179.25%
FREE CASH FLOW
Cash From Operating Activities	-$4.905M	-$13.31M	-$3.150M
Capital Expenditures	-$10.00K	-$410.0K	-$320.0K
Free Cash Flow	-$4.895M	-$12.90M	-$2.830M
YoY Change	72.46%	53.59%	-1148.15%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	105295	USD
CY2016Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	119688	USD
CY2017Q2	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	0	USD
CY2016Q2	us-gaap	Common Stock Value CommonStockValue	35114	USD
CY2016Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	52782569	USD
CY2017Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-64321962	USD
CY2016Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-44044830	USD
CY2016Q2	us-gaap	Stockholders Equity StockholdersEquity	8772853	USD
CY2016Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10903391	USD
CY2016Q2	us-gaap	Cash Cash	4062013	USD
CY2017Q2	us-gaap	Cash Cash	4486538	USD
CY2017Q2	us-gaap	Liabilities Liabilities	2100943	USD
CY2016Q2	us-gaap	Liabilities Liabilities	2130538	USD
CY2017	us-gaap	Manufacturing Costs ManufacturingCosts	2596809	USD
CY2017	antb	Compensation And Benefits For Research And Development CompensationAndBenefitsForResearchAndDevelopment	7001151	USD
CY2017	antb	Consultants And Outside Costs ConsultantsAndOutsideCosts	762670	USD
CY2017Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	588	USD
CY2016Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	400038	USD
CY2017	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2016Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	11955	USD
CY2017	dei	Entity Voluntary Filers EntityVoluntaryFilers	Yes
CY2017	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2017	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2016Q4	dei	Entity Public Float EntityPublicFloat	35448145	USD
CY2017	dei	Trading Symbol TradingSymbol	ANTB
CY2017Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	53728640	shares
CY2017Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	44322	USD
CY2016Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	51614	USD
CY2017Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	244341	USD
CY2016Q2	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	23128	USD
CY2017Q2	us-gaap	Interest Payable Current InterestPayableCurrent	2762	USD
CY2016Q2	us-gaap	Interest Payable Current InterestPayableCurrent	15079	USD
CY2017Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1771322	USD
CY2016Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1730500	USD
CY2017Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	304575	USD
CY2017Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	329621	USD
CY2016Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	400038	USD
CY2016Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1500650	USD
CY2017Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1652677	USD
CY2016Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	6411284	USD
CY2016Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	375000	USD
CY2016Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5984670	USD
CY2017Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5325401	USD
CY2016Q2	us-gaap	Assets Current AssetsCurrent	4492107	USD
CY2017Q2	us-gaap	Assets Current AssetsCurrent	4928553	USD
CY2016Q2	us-gaap	Other Assets Current OtherAssetsCurrent	430094	USD
CY2017Q2	us-gaap	Other Assets Current OtherAssetsCurrent	442015	USD
CY2016Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1231852	USD
CY2016	antb	Compensation And Benefits For Research And Development CompensationAndBenefitsForResearchAndDevelopment	4374763	USD
CY2016	antb	Consultants And Outside Costs ConsultantsAndOutsideCosts	1317465	USD
CY2016	us-gaap	Manufacturing Costs ManufacturingCosts	2414708	USD
CY2016	antb	Investor Relations InvestorRelations	259351	USD
CY2017	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	46916	USD
CY2016	antb	Compensation And Benefits For General And Administrative CompensationAndBenefitsForGeneralAndAdministrative	3891916	USD
CY2017	antb	Compensation And Benefits For General And Administrative CompensationAndBenefitsForGeneralAndAdministrative	5569426	USD
CY2016	us-gaap	Professional Fees ProfessionalFees	441978	USD
CY2017	us-gaap	Professional Fees ProfessionalFees	1100480	USD
CY2016	us-gaap	Operating Expenses OperatingExpenses	14951290	USD
CY2017	us-gaap	Operating Expenses OperatingExpenses	20324048	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	-14951290	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	-20324048	USD
CY2016	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	909657	USD
CY2016	us-gaap	Investment Income Interest InvestmentIncomeInterest	965	USD
CY2017	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	USD
CY2016	us-gaap	Interest Expense InterestExpense	5039	USD
CY2017	us-gaap	Interest Expense InterestExpense	1595	USD
CY2016	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	19822	USD
CY2017	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	11367	USD
CY2016	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	15748	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-14935542	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-20277132	USD
CY2016	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.84
CY2017	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.57
CY2017	antb	Investor Relations InvestorRelations	327556	USD
CY2017	antb	Facilities And Other Costs FacilitiesAndOtherCosts	1734104	USD
CY2016	antb	Facilities And Other Costs FacilitiesAndOtherCosts	1341452	USD
CY2017	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	USD
CY2016	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	5974385	USD
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-23684064	USD
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20909927	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6005670	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	5434987	USD
CY2017	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	11939004	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3761837	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	5523706	USD
CY2016	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3106437	USD
CY2015Q2	us-gaap	Stockholders Equity StockholdersEquity	9053807	USD
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7292	USD
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7292	USD
CY2016	us-gaap	Depreciation Depreciation	743962	USD
CY2017	us-gaap	Depreciation Depreciation	1106878	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	3761837	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	6005670	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-13311459	USD
CY2017	us-gaap	Cash Period Increase Decrease CashPeriodIncreaseDecrease	424525	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	10725928	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	13931367	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1454123	USD
CY2016	antb	Warrant Expense WarrantExpense	72972	USD
CY2017	antb	Warrant Expense WarrantExpense	12564	USD
CY2016	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-450167	USD
CY2017	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2015Q2	us-gaap	Cash Cash	5278706	USD
CY2016	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	2091790	USD
CY2017	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	407929	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-195383	USD
CY2017	us-gaap	Payments For Proceeds From Other Deposits PaymentsForProceedsFromOtherDeposits	-187500	USD
CY2016	us-gaap	Payments For Proceeds From Other Deposits PaymentsForProceedsFromOtherDeposits	-187500	USD
CY2016	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	26370	USD
CY2017	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	112347	USD
CY2017	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	14637689	USD
CY2016	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	5362521	USD
CY2017	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	683194	USD
CY2016	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	890357	USD
CY2017	us-gaap	Proceeds From Issuance Of Redeemable Preferred Stock ProceedsFromIssuanceOfRedeemablePreferredStock	0	USD
CY2016	us-gaap	Proceeds From Issuance Of Redeemable Preferred Stock ProceedsFromIssuanceOfRedeemablePreferredStock	6347615	USD
CY2013Q1	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	400000	USD
CY2013Q1	antb	Business Acquisition Purchases Price Allocation Assets Acquired BusinessAcquisitionPurchasesPriceAllocationAssetsAcquired	100000	USD
CY2014Q4	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	55000	USD
CY2017Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1986127	USD
CY2016Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	879250	USD
CY2017Q2	antb	Minimum Securities Value Purchase Commitments MinimumSecuritiesValuePurchaseCommitments	8000000	USD
CY2016Q2	us-gaap	Preferred Stock Redemption Price Per Share PreferredStockRedemptionPricePerShare	1.95
CY2016Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	512820	shares
CY2016Q2	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	1000000	USD
CY2017Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2017Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2017Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	12885590	USD
CY2017	antb	Fair Value Of Warrants FairValueOfWarrants	588	USD
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	5542631	USD
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	5065733	USD
CY2017	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	618192	USD
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	339091	USD
CY2017	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	6160823	USD
CY2016	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	5404824	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2017	antb	Operating Loss Carry Forwards Expiration Year OperatingLossCarryForwardsExpirationYear	2031
CY2017Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	6281000	USD
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34	pure
CY2017	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-6894226	USD
CY2016	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-5078084	USD
CY2017	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	617139	USD
CY2016	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	339091	USD
CY2017	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	18150	USD
CY2016	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	12351	USD
CY2014Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	28939	USD
CY2014Q2	antb	Payments Of Monthly Lease Adjusted Annually Percentage PaymentsOfMonthlyLeaseAdjustedAnnuallyPercentage	0.03	pure
CY2014Q2	antb	Adjusted Triple Net Expense Of Lease Payments AdjustedTripleNetExpenseOfLeasePayments	34381	USD
CY2014Q2	us-gaap	Area Of Land AreaOfLand	27000	sqft
CY2014Q2	us-gaap	Security Deposit SecurityDeposit	750000	USD
CY2017Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2017Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2017Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49228640	shares
CY2017Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49228640	shares
CY2016Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35110916	shares
CY2016Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35110916	shares
CY2017	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8229314	USD
CY2016	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5502902	USD
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9448388	USD
CY2017	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	37144	USD
CY2016	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	0	USD
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12094734	USD
CY2017	antb	Warrant Modification Deemed Dividend WarrantModificationDeemedDividend	-3406932	USD
CY2016	antb	Warrant Modification Deemed Dividend WarrantModificationDeemedDividend	0	USD
CY2017	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	41296741	shares
CY2016	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	24773213	shares
CY2016	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	5974385	USD
CY2016	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	5307909	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	2929084	USD
CY2017	antb	Increase Decrease In Deferred Lease Liability IncreaseDecreaseInDeferredLeaseLiability	-109856	USD
CY2016	antb	Increase Decrease In Deferred Lease Liability IncreaseDecreaseInDeferredLeaseLiability	-105484	USD
CY2017	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	68762	USD
CY2016	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	42083	USD
CY2017	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-2800	USD
CY2016	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	2000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	7292	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	7292	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	7292	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	7292	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	7292	USD
CY2017	us-gaap	Income Tax Examination Likelihood Of Unfavorable Settlement IncomeTaxExaminationLikelihoodOfUnfavorableSettlement	An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained.
CY2016	us-gaap	Interest Paid InterestPaid	0	USD
CY2017Q2	antb	Operating Leases Future Minimum Payments Remainder Of Fiscal Year Gross OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYearGross	691422	USD
CY2017Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7311528	USD
CY2016Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6863920	USD
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	6657568	shares
CY2017Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	50000	USD
CY2015Q4	us-gaap	Preferred Stock Conversion Basis PreferredStockConversionBasis	The Series A Stock had a conversion feature at the option of the holder that could be converted at any time at a conversion rate of $1.95, subject to adjustment, into common stock. The shares also had a mandatory conversion feature at the same conversion rate if one of the following events occurs: 1) Upon vote or consent of 2/3 of the then outstanding Series A Stock; 2) Upon the Companys listing to NASDAQ Stockmarket or the NYSE MKT and the Companys common stock trades for 30 days for at least 155% of the Series A Stock conversion price; or 3) the Company closes an underwritten public offering of at least $15 million in gross proceeds with an offering price of at least 155% of the Series A Stock conversion price. The Series A Stocks conversion price was subject to weighted average anti-dilution protection, as defined, and was subject to adjustments for stock splits, dividends, and similar events.
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.78
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.07
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.66
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8702418	shares
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	285000	shares
CY2016	us-gaap	Stock Issued During Period Shares Share Based Compensation Forfeited StockIssuedDuringPeriodSharesShareBasedCompensationForfeited	40000	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8947418	shares
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	24725000	shares
CY2017	us-gaap	Stock Issued During Period Shares Share Based Compensation Forfeited StockIssuedDuringPeriodSharesShareBasedCompensationForfeited	125000	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	21290751	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.73
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.19
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.12
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.65
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.30
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y8M12D
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y3M18D
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	19016391	shares
CY2016	antb	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Warrants Issued For Stock Conversion ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWarrantsIssuedForStockConversion	5897677	shares
CY2016	antb	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Warrants Issued To Private Placement ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWarrantsIssuedToPrivatePlacement	3043669	shares
CY2016	antb	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Warrants Issued To Placement Agent ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWarrantsIssuedToPlacementAgent	933639	shares
CY2016	antb	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Warrants Issued For Investyor Relations ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWarrantsIssuedForInvestyorRelations	103000	shares
CY2016	antb	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Warrants Cancelled In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWarrantsCancelledInPeriod	30000	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	28964376	shares
CY2017	antb	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Warrants Issued To Private Placement ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWarrantsIssuedToPrivatePlacement	3248184	shares
CY2017	antb	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Warrants Issued To Placement Agent ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWarrantsIssuedToPlacementAgent	786150	shares
CY2017	antb	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Warrants Issued For Consulting Services ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWarrantsIssuedForConsultingServices	250000	shares
CY2017	antb	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Warrants Expired In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWarrantsExpiredInPeriod	452262	shares
CY2015Q2	antb	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Non Vested Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedWeightedAverageExercisePrice	2.33
CY2016	antb	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercise Price Warrants Issued For Stock Conversion ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisePriceWarrantsIssuedForStockConversion	1.65
CY2016	antb	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercise Price Warrants Issued To Private Placement ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisePriceWarrantsIssuedToPrivatePlacement	1.65
CY2016	antb	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercise Price Warrants Issued To Placement Agent ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisePriceWarrantsIssuedToPlacementAgent	1.61
CY2016	antb	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercise Price Warrants Issued For Investyor Relations ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisePriceWarrantsIssuedForInvestyorRelations	1.60
CY2016	antb	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Non Vested Weighted Average Exercise Price Warrants Cancelled In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedWeightedAverageExercisePriceWarrantsCancelledInPeriod	3.44
CY2016Q2	antb	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Non Vested Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedWeightedAverageExercisePrice	2.11
CY2017	antb	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercise Price Warrants Issued To Private Placement ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisePriceWarrantsIssuedToPrivatePlacement	1.65
CY2017	antb	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercise Price Warrants Issued To Placement Agent ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisePriceWarrantsIssuedToPlacementAgent	1.54
CY2017	antb	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercise Price Warrants Issued For Consulting Services ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisePriceWarrantsIssuedForConsultingServices	1.00
CY2017	antb	Share Based Compensation Arrangements By Share Based Payment Award Options Expired In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpiredInPeriodWeightedAverageExercisePrice	2.39
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2017Q2	us-gaap	Deferred Costs Leasing Net Noncurrent DeferredCostsLeasingNetNoncurrent	86293	USD
CY2016Q2	us-gaap	Deferred Costs Leasing Net Noncurrent DeferredCostsLeasingNetNoncurrent	0	USD
CY2017Q2	us-gaap	Deposits Deposits	25046	USD
CY2016Q2	us-gaap	Deposits Deposits	0	USD
CY2017	us-gaap	Increase Decrease In Deferred Leasing Fees IncreaseDecreaseInDeferredLeasingFees	86293	USD
CY2016	us-gaap	Increase Decrease In Deferred Leasing Fees IncreaseDecreaseInDeferredLeasingFees	0	USD
CY2017	us-gaap	Sublease Income SubleaseIncome	-25046	USD
CY2016	us-gaap	Sublease Income SubleaseIncome	0	USD
CY2017	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2016	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2017	us-gaap	Interest Paid InterestPaid	0	USD
CY2017Q2	us-gaap	Future Minimum Sublease Rentals Sale Leaseback Transactions Within Five Years FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinFiveYears	0	USD
CY2017Q2	us-gaap	Future Minimum Sublease Rentals Sale Leaseback Transactions Thereafter FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter	0	USD
CY2017Q2	us-gaap	Future Minimum Sublease Rentals Sale Leaseback Transactions FutureMinimumSubleaseRentalsSaleLeasebackTransactions	457743	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	539417	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	555173	USD
CY2017Q2	antb	Operating Leases Future Minimum Payments Due In Two Years Gross OperatingLeasesFutureMinimumPaymentsDueInTwoYearsGross	712360	USD
CY2017Q2	antb	Operating Leases Future Minimum Payments Due In Three Years Gross OperatingLeasesFutureMinimumPaymentsDueInThreeYearsGross	664696	USD
CY2017Q2	antb	Operating Leases Future Minimum Payments Due In Four Years Gross OperatingLeasesFutureMinimumPaymentsDueInFourYearsGross	338392	USD
CY2017Q2	antb	Operating Leases Future Minimum Payments Due In Five Years Gross OperatingLeasesFutureMinimumPaymentsDueInFiveYearsGross	347836	USD
CY2017Q2	antb	Operating Leases Future Minimum Payments Due Thereafter Gross OperatingLeasesFutureMinimumPaymentsDueThereafterGross	569364	USD
CY2017Q2	antb	Operating Leases Future Minimum Payments Due Gross OperatingLeasesFutureMinimumPaymentsDueGross	3324070	USD
CY2017Q2	us-gaap	Future Minimum Sublease Rentals Sale Leaseback Transactions Remainder Of Fiscal Year FutureMinimumSubleaseRentalsSaleLeasebackTransactionsRemainderOfFiscalYear	152005	USD
CY2017Q2	us-gaap	Future Minimum Sublease Rentals Sale Leaseback Transactions Within Two Years FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears	157187	USD
CY2017Q2	us-gaap	Future Minimum Sublease Rentals Sale Leaseback Transactions Within Three Years FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears	148551	USD
CY2017Q2	us-gaap	Future Minimum Sublease Rentals Sale Leaseback Transactions Within Four Years FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinFourYears	0	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	516145	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	338392	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	347836	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	569364	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	2866327	USD
CY2017	antb	Investor Relations Expense InvestorRelationsExpense	113175	USD
CY2014Q2	us-gaap	Proceeds From Other Deposits ProceedsFromOtherDeposits	375000	USD
CY2017	antb	Conversionofconvertiblenotespayabletocommonstock Conversionofconvertiblenotespayabletocommonstock	50000	USD
CY2016	antb	Conversionofconvertiblenotespayabletocommonstock Conversionofconvertiblenotespayabletocommonstock	0	USD
CY2017	antb	Conversionofinterestpayabletocommonstock Conversionofinterestpayabletocommonstock	9517	USD
CY2016	antb	Conversionofinterestpayabletocommonstock Conversionofinterestpayabletocommonstock	0	USD
CY2017	antb	Warrantvaluerecordedasdebtdiscount Warrantvaluerecordedasdebtdiscount	3406932	USD
CY2016	antb	Warrantvaluerecordedasdebtdiscount Warrantvaluerecordedasdebtdiscount	0	USD
CY2017	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2016	us-gaap	Stock Issued1 StockIssued1	162677	USD
CY2017	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2016	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	5923200	USD
CY2017	antb	Warrant Value Recorded As Issuance Cost WarrantValueRecordedAsIssuanceCost	753079	USD
CY2016	antb	Warrant Value Recorded As Issuance Cost WarrantValueRecordedAsIssuanceCost	750484	USD
CY2017	antb	Deemed Dividend On Conversion Of Preferred Stock DeemedDividendOnConversionOfPreferredStock	0	USD
CY2016	antb	Deemed Dividend On Conversion Of Preferred Stock DeemedDividendOnConversionOfPreferredStock	5811708	USD
CY2017Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.65
CY2017Q2	antb	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Modification ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsModification	285834	shares
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms	extend the terms of the warrants for an additional two years
CY2017	antb	Adjustments To Additional Paid In Capital Warrant Modification AdjustmentsToAdditionalPaidInCapitalWarrantModification	3406932	USD
CY2017	antb	Stock Issued During Period Value Conversion Of Note Payable StockIssuedDuringPeriodValueConversionOfNotePayable	59517	USD
CY2017	us-gaap	Nature Of Operations NatureOfOperations	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b><u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Note 1 Nature of Operations</u></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b> </b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; DIRECTION: ltr" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">These financial statements represent the consolidated financial statements of AntriaBio, Inc. (“AntriaBio”), and its wholly owned operating subsidiary, AntriaBio Delaware, Inc. (“Antria Delaware”). AntriaBio, and Antria Delaware, are collectively referred to herein as the “Company”. The Company is a clinical stage biopharmaceutical Company.</div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2017Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	529096	USD
CY2016Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	265809	USD
CY2017Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	21539926	USD
CY2016Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	15840906	USD
CY2017Q2	antb	Deferred Tax Liabilities Non Current Assets DeferredTaxLiabilitiesNonCurrentAssets	349346	USD
CY2016Q2	antb	Deferred Tax Liabilities Non Current Assets DeferredTaxLiabilitiesNonCurrentAssets	1072872	USD
CY2017	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><strong><i>Accounting Estimates</i></strong> - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the financial statements and the accompanying notes. Such estimates and assumptions impact, among others, the following: the useful lives of depreciable assets, the fair value of share-based payments and warrants, fair value of derivative instruments, estimates of the probability and potential magnitude of contingent liabilities, the valuation allowance for deferred tax assets due to continuing and expected future operating losses, going concern analysis and the impairment of long-lived assets. Actual results could differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q2	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	11955	USD
CY2017	antb	Fair Value Of Financial Instruments Earnings FairValueOfFinancialInstrumentsEarnings	11367	USD
CY2017Q2	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	588	USD
CY2017	us-gaap	Income Tax Reconciliation Deductions Other IncomeTaxReconciliationDeductionsOther	205794	USD
CY2016	us-gaap	Income Tax Reconciliation Deductions Other IncomeTaxReconciliationDeductionsOther	0	USD
CY2017	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	1538186	USD
CY2016	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	0	USD
CY2017	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	8100000	USD
CY2017	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	186671	USD
CY2017	antb	Stockissued During Period Sharess Hare Based Compensation Cancelledshares StockissuedDuringPeriodSharessHareBasedCompensationCancelledshares	12256667	shares
CY2017	antb	Share Based Compensation Arrangements By Share Based Payment Award Options Cancelled In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrice	1.51
CY2017Q2	antb	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Non Vested Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedWeightedAverageExercisePrice	1.71
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	32796448	shares
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P3Y
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P3Y1M6D
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P3Y8M16D
CY2017Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	15358843	USD
CY2016Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	10602681	USD
CY2017Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	540221	USD
CY2016Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	577110	USD
CY2017Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	5111766	USD
CY2017Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	20327049	USD
CY2016Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	14166226	USD
CY2016Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	4395306	USD
CY2017Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2016Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2017	antb	Repayments Of Capital Lease Payable RepaymentsOfCapitalLeasePayable	23128	USD
CY2016	antb	Repayments Of Capital Lease Payable RepaymentsOfCapitalLeasePayable	93851	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	11090000	shares
CY2017Q2	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	863531	USD
CY2016Q2	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	601808	USD
CY2017Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1212877	USD
CY2016Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1674680	USD

Files In Submission

Name	View Source	Status
0001144204-17-049237-index-headers.html	Edgar Link	pending
0001144204-17-049237-index.html	Edgar Link	pending
0001144204-17-049237.txt	Edgar Link	pending
0001144204-17-049237-xbrl.zip	Edgar Link	pending
antb-20170630.xml	Edgar Link	completed
antb-20170630.xsd	Edgar Link	pending
antb-20170630_cal.xml	Edgar Link	unprocessable
antb-20170630_def.xml	Edgar Link	unprocessable
antb-20170630_lab.xml	Edgar Link	unprocessable
antb-20170630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v474916_10k.htm	Edgar Link	pending
v474916_ex10-25.htm	Edgar Link	pending
v474916_ex10-35.htm	Edgar Link	pending
v474916_ex10-36.htm	Edgar Link	pending
v474916_ex21-1.htm	Edgar Link	pending
v474916_ex23-1.htm	Edgar Link	pending
v474916_ex31-1.htm	Edgar Link	pending
v474916_ex31-2.htm	Edgar Link	pending
v474916_ex32-1.htm	Edgar Link	pending
v474916_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RZLT
Rezolute, Inc. Stock $rzlt

2017 Q3 Form 10-K Financial Statement

#000114420417049237 Filed on September 22, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RZLT Rezolute, Inc. Stock $rzlt

2017 Q3 Form 10-K Financial Statement

#000114420417049237 Filed on September 22, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RZLT
Rezolute, Inc. Stock $rzlt